Regulatory Changes, Business Impact 3 Jan 2025 procurement, federal contracts, small business, blind services, regulatory compliance

📉Impact of Procurement List Deletions on Small Businesses

This action deletes product(s) from the Procurement List that were furnished by nonprofit agencies employing persons who are blind or have other severe disabilities.

Learn More
Regulatory Compliance, Financial Implications 3 Jan 2025 connectivity fees, financial services, regulatory compliance, trading floors, nyse
Regulatory Compliance, Environmental Impact 3 Jan 2025 business operations, regulatory compliance, arizona, endangered species, conservation

🌿Eagle Creek Conservation Permit Notice for Freeport Minerals

We, the U.S. Fish and Wildlife Service, have received an application from Freeport Minerals, a subsidiary of Freeport-McMoRan Inc., for a 10(a)(1)(A) enhancement of survival permit supported by the proposed Eagle Creek Multi-Species Conservation Benefit Agreement (CBA) in Greenlee and Graham Counties, Arizona. With this notice, we announce the availability for public comment of the permit application, the proposed CBA, and the draft environmental assessment (EA). We invite comments from the public and Federal, Tribal, State, and local governments.

Learn More
Regulatory Compliance, Professional Events 3 Jan 2025 fda, pharmaceuticals, regulatory compliance, drug development, pediatric research, public health

💊FDA Meeting

The Food and Drug Administration's (FDA, Agency, or we) Office of Pediatric Therapeutics, the Center for Drug Evaluation and Research, and the Center for Biologics Evaluation and Research are announcing a public meeting entitled "Interested Parties Meeting: Implementation of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act." The purpose of the public meeting is to seek input from interested parties, including patient/parent/ caregiver groups, consumer groups, regulated industry, academia, and others. This input will enable FDA to obtain any recommendations or information relevant to the report to Congress that FDA is required to submit concerning pediatric drug and biologic development and labeling, as outlined in section 508 of the Food and Drug Administration Safety and Innovation Act (FDASIA).

Learn More
Regulatory Notice 3 Jan 2025 meeting notice, sunshine act, regulatory compliance, enforcement, sec
Compliance, Regulation 3 Jan 2025 cfpb, supervision records, regulatory compliance, consumer finance, privacy act

🔍CFPB Proposes Rescindment of Privacy Act Records System Notice

Pursuant to the Privacy Act of 1974, and Office of Management and Budget (OMB) Circular No. A-108, the Consumer Financial Protection Bureau (CFPB) proposes to rescind existing system of records "CFPB.003 Non-Depository Institution Supervision Database." Records maintained under this system of records have been consolidated into the modified "CFPB.002 Supervision and Examination Records."

Learn More